前沿论文｜CELL INTELLIGENCE

Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.

PubMed 2025/07/07 发表Mol CancerQ1 · IF 42.2（JCR 2025）

CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.

PubMed 2024/10/01 发表Nat CancerQ1 · IF 28（JCR 2025）

Harnessing Chimeric Antigen Receptor-engineered Invariant Natural Killer T Cells: Therapeutic Strategies for Cancer and the Tumor Microenvironment.

PubMed 2024/01/01 发表Curr Pharm BiotechnolQ2 · IF 2.9（JCR 2025）

前沿论文 3